Associated Papers
Succinate dehydrogenase variants in paraganglioma: why are B subunit variants 'bad'?
Gruber LM et al.
Endocrine Oncology (bristol, England), 2023
37434649 (PubMed )
Supplement: supplementary_table_1.xlsx › Missense_Variants
Quantifying evidence toward pathogenicity for rare phenotypes: The case of succinate dehydrogenase genes, SDHB and SDHD.
Garrett A et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics, 2022
34906457 (PubMed )
Supplement: mmc1.xlsx › SupTable2_Variant_Counts
An adaptive method of defining negative mutation status for multi-sample comparison using next-generation sequencing.
Hutson N et al.
Bmc Medical Genomics, 2021
34856988 (PubMed )
Supplement: 12920_2021_880_MOESM1_ESM.xls › Table_S1
Signalling pathways in succinate dehydrogenase B-associated renal carcinoma.
Fleming S et al.
Histopathology, 2014
Select a paper to view details